Tanuj Bhatnagar, MD
Sleep Medicine · Jersey City, NJNPI 1205918679
Payments from drug & device makers
Across 335 payments — averaging $2969.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$710K
- AstraZeneca$257K
- Ionis Pharmaceuticals, Inc.$23K
- GSK$3K
- Mylan Specialty L.p.$453
- Mallinckrodt Hospital Products Inc.$203
- plus $1K from 22 others
What the payments were for
- Food & beverage$6,986100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $709,659 |
| AstraZeneca | 75 | $257,188 |
| Ionis Pharmaceuticals, Inc. | 10 | $22,867 |
| GSK | 125 | $2,907 |
| Mylan Specialty L.p. | 23 | $453 |
| Mallinckrodt Hospital Products Inc. | 12 | $203 |
| Boehringer Ingelheim | 10 | $157 |
| Edwards Lifesciences | 2 | $145 |
| Regeneron Healthcare Solutions, Inc. | 9 | $139 |
| Philips North America LLC | 7 | $134 |
| Verona Pharma, Inc. | 7 | $126 |
| Viatris Specialty LLC | 5 | $103 |
| Inspire Medical Systems, Inc. | 4 | $93 |
| Teva Pharmaceuticals USA, Inc. | 6 | $83 |
| Electromed, Inc. | 6 | $82 |
| Merck | 5 | $76 |
| Jazz Pharmaceuticals Inc. | 4 | $55 |
| Insmed, Inc. | 3 | $47 |
| Sanofi | 2 | $31 |
| Sunovion Pharmaceuticals Inc. | 2 | $30 |
| Mallinckrodt Enterprises LLC | 2 | $27 |
| Boston Scientific | 1 | $23 |
| Pulmonx Corporation | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Harmony Biosciences LLC | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| 3b Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$744
- AREXVY$250
- BREZTRI$238
- SYMBICORT$141
- BEVESPI AEROSPHERE$141
- Edwards SAPIEN 3 Transcatheter Heart Valve$130
- AIRSUPRA$126
- FARXIGA$121
How this compares
$994,734 in reported general payments places this provider in the 95th percentile of 40 sleep medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 598 | $421,155 |
| OfevNintedanib Esylate | 18 | $241,891 |
| Breo ElliptaFluticasone/Vilanterol | 324 | $157,150 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 147 | $106,882 |
| EliquisApixaban | 63 | $19,508 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 123 | $16,471 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 600 | $13,670 |
| Arnuity ElliptaFluticasone Furoate | 53 | $12,536 |
| Incruse ElliptaUmeclidinium Bromide | 23 | $7,425 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $5,710 |
| Serevent DiskusSalmeterol Xinafoate | 14 | $5,481 |
| Fluticasone-VilanterolFluticasone/Vilanterol | 13 | $5,178 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $3,307 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 25 | $2,964 |
| Montelukast Sodium | 292 | $2,153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta, Incruse Ellipta, Anoro Ellipta | $2,907 | $603,9751,011 claims |
| Boehringer IngelheimOfev | $157 | $241,89118 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $257,188 | $110,189162 claims |
| Lilly USA, LLCInsulin Lispro | $19 | $40113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 40 sleep medicine providers in New Jersey.
Other sleep medicine in Jersey City
- Prashant PatelBridgewater$20K
- Nehal MehtaBridgewater$19K
- Federico CerroneSummit$13K
- Thanuja HamiltonMount Laurel$9K
- Jimmy HannaNewark$7K
- Bankim ShahBoonton$7K
- Kalpeshkumar PatelOld Bridge$5K
- David OczosNeptune$4K
- Divya GuptaEdison$3K
- Wajahat KhanFlemington$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.